Carotid stenting (CAS) has emerged as a useful and potentially less invasive alternative to carotid endarterectomy (CEA). Current technical recommendations for CAS will be described. Pre-procedural antiplatelet therapy and intraprocedural heparinization (ACT 250-300) are employed. An anti-embolic device is used in association with nitinol stents to achieve a satisfactory result. Thirty-day stroke and death for CAS are comparable to CEA for higher risk patient subsets.
Technical considerations in carotid artery stenting
Home > Technical considerations in carotid artery stenting
